News & Events Year None2022202120202019201820172016201520142013201220112009 01/10/22 REGENXBIO Announces Initiation of Second Pivotal Trial in RGX-314 Clinical Program for the Treatment of Wet AMD Using Subretinal Delivery 01/06/22 REGENXBIO Announces FDA Clearance of IND for Clinical Trial of RGX-202, a Novel Gene Therapy Candidate for Duchenne Muscular Dystrophy Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Current page 4
